Cargando…
An overview of JAK/STAT pathways and JAK inhibition in alopecia areata
Alopecia Areata (AA) is a common autoimmune disease characterized by non-scarring hair loss ranging from patches on the scalp to complete hair loss involving the entire body. Disease onset is hypothesized to follow the collapse of immune privilege of the hair follicle, which results in an increase i...
Autores principales: | Lensing, Maddison, Jabbari, Ali |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9470217/ https://www.ncbi.nlm.nih.gov/pubmed/36110853 http://dx.doi.org/10.3389/fimmu.2022.955035 |
Ejemplares similares
-
Induction of T cell exhaustion by JAK1/3 inhibition in the treatment of alopecia areata
por: Dai, Zhenpeng, et al.
Publicado: (2022) -
Efficacy and safety of different JAK inhibitors in the treatment of alopecia areata: a network meta-analysis
por: Wei, Dongfan, et al.
Publicado: (2023) -
Reversal of Alopecia Areata Following Treatment With the JAK1/2 Inhibitor Baricitinib
por: Jabbari, Ali, et al.
Publicado: (2015) -
A Comment on JAK Inhibitors for Treatment of Alopecia Areata
por: Trüeb, Ralph Michel, et al.
Publicado: (2018) -
Selective inhibition of JAK3 signaling is sufficient to reverse alopecia areata
por: Dai, Zhenpeng, et al.
Publicado: (2021)